WallStreetZenWallStreetZen

NYSEMKT: NSRX
Nasus Pharma Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Nasus Pharma earnings were -$5.9M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest NSRX earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NSRX reported annual earnings of -$5.9M, with 282.2% growth.

NSRX earnings history

Current Revenue
$0.0
Current Earnings
-$5.9M
Current Profit Margin
0%

NSRX Return on Equity

Insufficient data to display

NSRX Return on Assets

Current Company
-204.7%
Current Industry
12.6%
NSRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NSRX announces earnings.

NSRX Return on Capital Employed

Current Company
-208.87%
Current Industry
21.4%

NSRX vs General Drug Manufacturer Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NSRX-$5.92M-$5.86MN/A-$0.72
MDCX-$35.25M-$47.28MN/A-$2.74
MIRA-$5.60M-$48.71MN/A-$2.63
SCLX-$319.06M-$375.84MN/A-$31.85
AMRN-$33.01M-$38.80MN/A-$1.80
View Top General Drug Manufacturer Stocks

Nasus Pharma Earnings Reports & History FAQ

What were Nasus Pharma's earnings last quarter?

On NSRX's earnings call on Invalid Date, Nasus Pharma (NYSEMKT: NSRX) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total NSRX earnings for the quarter were N/A. In the same quarter last year, Nasus Pharma's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Nasus Pharma stock.

Is Nasus Pharma profitable or losing money?

As of the last Nasus Pharma earnings report, Nasus Pharma is currently losing money. Nasus Pharma's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$5.86 million, a 282.25% increase year over year.

What was NSRX's earnings growth in the past year?

As of Nasus Pharma's earnings date in Invalid Date, Nasus Pharma's earnings has grown year over year. NSRX earnings in the past year totalled -$5.86 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.